To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia
Condition(s):Ventilator-Associated PneumoniaLast Updated:December 28, 2012Terminated
Hide Studies Not Open or Pending
Condition(s):Ventilator-Associated PneumoniaLast Updated:December 28, 2012Terminated
Condition(s):Febrile Neutropenia; Hematological MalignancyLast Updated:September 25, 2019Completed
Condition(s):Skin Infection; Abscess; CellulitisLast Updated:September 1, 2017Completed
Condition(s):Urinary Tract Infection; Acute PyelonephritisLast Updated:March 8, 2024Recruiting
Condition(s):Infections, Urinary TractLast Updated:September 8, 2017Terminated
Condition(s):Septicemia; Bacterial InfectionsLast Updated:February 21, 2021Unknown status
Condition(s):Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)Last Updated:November 22, 2023Not yet recruiting
Condition(s):Acute PancreatitisLast Updated:June 20, 2017Completed
Condition(s):SepsisLast Updated:September 22, 2023Completed
Condition(s):Bacterial InfectionsLast Updated:February 16, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.